Myomo Inc. (MYO) Stock Price
MYOStock
$1.20+11.11%52W
Market Cap$47.53M
P/E—
PEG Ratio—
Div yield—
Beta1.73
MYO Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)41.61%
Price vs S&P 500 (4W)-22.24%
VGM Score66.70
MYO Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.10 | -$0.07 | +33.92%(+$0.03) | |
| Q1 2026 | -$0.12 | -$0.09 | +20.87%(+$0.02) | |
| Q4 2025 | -$0.09 | -$0.09 | -0.24%(-$0.00) | |
| Q3 2025 | -$0.11 | -$0.09 | +16.67%(+$0.02) | |
| Q2 2025 | -$0.11 | -$0.11 | -3.77%(-$0.00) |
MYO Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.00
4.00
4.00
4.00
Industry Peers — Orthopedic & Prosthetic Devices(31)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
MYOMyomo Inc. | B | B | B | 1.1x | 40.1% | 68.3% | -27.1% | $1.20 |
| ISRGIntuitive Surgical Inc. | D | B | B | 13.7x | 18.2% | 66.7% | 31.3% | $426.70 |
| EWEdwards Lifesciences Corp | D | C | B | 7.7x | 6.7% | 77.8% | 18.2% | $86.60 |
| STESTERIS plc | C | C | B | 3.6x | 13.8% | 44.4% | 18.9% | $222.66 |
| ZBHZimmer Biomet Holdings, Inc. | B | C | B | 2.1x | 3.2% | 69.9% | 14.2% | $94.98 |
| SNNSmith & Nephew plc | B | C | C | 1.9x | 6.2% | 68.2% | 12.9% | $29.06 |
| ALGNAlign Technology Inc | B | D | C | 2.5x | 10.3% | 69.0% | 13.2% | $147.31 |
| MSAMine Safety Incorporated | C | C | B | 3.5x | 6.8% | 47.6% | 21.2% | $179.05 |
| ESTAEstablishment Labs Holdings Inc. | F | A | C | 7.2x | 20.0% | 70.5% | -7.6% | $59.18 |
| ENOVEnovis Corporation | B | D | C | 0.5x | -6.0% | 61.4% | -45.1% | $19.59 |
| CDRECadre Holdings, Inc. | B | C | C | 1.6x | 8.6% | 41.8% | 10.1% | $26.38 |
About Myomo Inc.
Myomo Inc manufactures MyoPro, an FDA-cleared Class II myoelectric orthosis designed to restore upper limb function in patients with neuromuscular disorders. The company distributes through orthotics and prosthetics providers worldwide and the Veterans Health Administration, while generating revenue through direct insurance billing for patient usage.